Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | الكتروني كتاب الكتروني |
| اللغة: | الإنجليزية |
| منشور في: |
Hamburg, Germany :
Anchor Academic Publishing,
2014.
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | An electronic book accessible through the World Wide Web; click to view |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة: Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
- Continuous processing in pharmaceutical manufacturing /
- Biomedical chromatography
- Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
- WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
- The war against counterfeit medicine my story /
- Analytical method validation and instrument performance verification